7V0 — Darwin AG Income Statement
0.000.00%
HealthcareSpeculativeSmall Cap
- €82.80m
- €85.08m
- €18.17m
Annual income statement for Darwin AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|
| Period Length: | 42 W | 12 M | 12 M |
| Source: | ARS | ARS | ARS |
| Standards: | GAS | GAS | GAS |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 111 | 210 | 18.2 |
| Cost of Revenue | |||
| Gross Profit | 55.2 | 120 | 6.03 |
| Selling / General / Administrative Expenses | |||
| Depreciation and Amortization | |||
| Unusual Expense / Income | |||
| Other Operating Expenses | |||
| Total Operating Expenses | 81.4 | 151 | 26.7 |
| Operating Profit | 29.5 | 59.2 | -8.56 |
| Total Net Non Operating Interest Income / Expense | |||
| Net Income Before Taxes | 29.5 | 59.7 | 3.02 |
| Provision for Income Taxes | |||
| Net Income After Taxes | 19.4 | 45.1 | 0.04 |
| Net Income Before Extraordinary Items | |||
| Net Income | 19.4 | 45.1 | 0.04 |
| Adjustments to Net Income | |||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | 19.4 | 45.1 | 0.04 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | 6.5 | 16.5 | 1.17 |
| Dividends per Share |